Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6

Oncogene volume 19, pages 5884–5891 (2000)Cite this article

Abstract

The protein Kinase A (PKA) pathway was found to selectively regulate the function of oncogenic but not non-oncogenic E6 proteins. High risk E6 proteins are phosphorylated at their Dlg/PDZ binding motif at the C-terminus by a PKA like activity. This PKA and PDZ binding module is found only for human PV, is strictly conserved in all the transforming HPVs and is absent in all the low risk HPV types. We present evidence of a conditional regulation of E6 induced degradation of Dlg. HPV18E6 positive but not HPV negative keratinocytes exhibit increased Dlg steady state levels under conditions of high PKA activity, with a concomitant increase in the presence of Dlg at tight junctions. In vitro binding experiments show that E6 phosphorylation by PKA reduces its binding to Dlg and molecular modelling can explain this observation in a structural context. E6 dependent degradation of Dlg in cells with high PKA levels is inhibited and this is dependent on phosphorylation of the PDZ binding site in E6. In contrast, the degradation of p53 induced by E6 is not affected by PKA. We propose a differential regulation of E6 for the ubiquitin mediated degradation of specific E6 target proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Balda SM and Matter K. . 1998 J. Cell Sci. 111: 541–547.

  • Banks L, Matlashewski G and Crawford L. . 1986 Eur. J. Biochem. 159: 529–534.

  • Boynton AL and Whitefield JF. . 1983 Adv. Cycl. Nucl. Res. 15: 193–294.

  • Cabral JH, Petosa C, Sutcliffe MJ, Raza S, Byron O, Marfatia SM, Chishti AH and Liddington RC. . 1996 Nature 382: 649–652.

  • Cho-Chung YS. . 1990 Cancer Res. 50: 7093–7100.

  • Cohen NA, Brenman JE, Snyder SH and Bredt DS. . 1996 Neuron 17: 759–767.

  • Crook T, Tidy JA and Vousden K. . 1991 Cell 67: 547–556.

  • de Villiers EM, Lavergne D, McLaren K and Benton C. . 1997 Int. J. Cancer 73: 356–361.

  • Doyle D, Lee A, Lewis J, Kim E, Sheng M and MacKinnon R. . 1996 Cell 85: 1067–1076.

  • Edelmann HM, Kühne C, Petritsch C and Ballou L. . 1996 J. Biol. Chem. 271: 963–971.

  • Fernandez A, Cavadore JC, Demaille J and Lamb N. . 1995 Prog. Cell Cycle Res. 1: 241–253.

  • Foster SA, Demers GW, Etscheid BG and Galloway DA. . 1994 J. Virol. 68: 5698–5705.

  • Gao Q, Kumar A, Srinivasan S, Singh L, Mukai H, Ono Y, Wazer DE and Band V. . 2000 J. Biol. Chem. 275: 14824–14830.

  • Gardiol D, Kühne C, Glausinger B, Lee SS, Javier R and Banks L. . 1999 Oncogene 18: 5487–5496.

  • Glass DB, Cheng HC, Mueller LM, Reed J and Walsh DA. . 1989 J. Biol. Chem. 264: 8802–8810.

  • Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias K, Schwartz A, Kahana C and Ciechanover A. . 1998 Proc. Natl. Acad. Sci. USA 95: 8058–8063.

  • Hateboer G, Timmers HTM, Rustgi AK, Billaud M, van't Veer L and Bernards R. . 1993 Proc. Natl. Acad. Sci. USA 90: 8489–8493.

  • Kato JY, Matsuoka M, Polyak K, Massague J and Sherr CJ. . 1994 Cell 79: 487–496.

  • Kemp BE, Bylund DB, Tung-Shiuh H and Krebs EG. . 1975 Proc. Nat. Acad. Sci. USA 72: 3448–3452.

  • Kinzler KW and Vogelstein B. . 1996 Cell 87: 159–170.

  • Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ. . 1998 Nature 396: 84–88.

  • Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T and Ishibashi M. . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616.

  • Krebs EG and Beavo JA. . 1979 Annu. Rev. Biochem. 48: 923–939.

  • Kühne C and Banks L. . 1998 J. Biol. Chem. 273: 34302–34309.

  • Lee S, Weiss R and Javier R. . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675.

  • Leighton IA, Dalby KN, Caudwell FB, Cohen PTW and Cohen P. . 1995 FEBS Letts 375: 289–293.

  • Liu Y, Chen JJ, Gao Q, Dalal S, Hong Y, Mansur CP, Band V and Androphy EJ. . 1999 J. Virol. 73: 7297–7307.

  • Maki CG, Huibregtse JM and Howley PM. . 1996 Cancer Res. 56: 2649–2654.

  • Pan H and Griep AE. . 1994 Genes Dev. 8: 1285–1299.

  • Pan H and Griep A. . 1995 Genes Dev. 9: 2157–2169.

  • Pim D, Storey A, Thomas M, Massimi P and Banks L. . 1994 Oncogene 9: 1869–1876.

  • Ponting CP, Phillips C, Davies KE and Blake DJ. . 1997 Bioessays 19: 469–479.

  • Scheffner M, Nuber U and Huibregtse LM. . 1995 Nature 375: 81–83.

  • Sherman L, Jackman A, Itzhaki H, Conrad Stöppler M, Koval D and Schlegel R. . 1997 Virology 237: 296–303.

  • Sherman L and Schlegel R. . 1996 J. Virol. 70: 3269–3279.

  • Song S, Pitot HC and Lambert P. . 1999 J. Virol. 73: 5887–5893.

  • Taylor SS, Buecheler JA and Yonemoto W. . 1990 Annu. Rev. Biochem. 59: 971–1005.

  • Thomas M and Banks L. . 1998 Oncogene 17: 2943–2954.

  • Uhler MD and McKnight GS. . 1987 J. Biol. Chem. 262: 15202–15207.

  • Werness BA, Levine AJ and Howley PM. . 1990 Science 248: 76–79.

  • Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW. . 1993 Science 262: 1065–1069.

  • zur Hausen H. . 1991 Science 254: 1167–1173.

  • zur Hausen H. . 1996 Biochim. Biophys. Acta 1288: F55–F78.

Download references

Acknowledgements

We are most grateful to SG McKnight for the PKA expressing plasmid, and to R Javier for the HA-18E6 expressing plasmid, also to F Mantovani and C Meyers for allowing us to cite their unpublished work. This work was funded in part by a research grant from the EU Biomed 2 program.

Author information

Authors and Affiliations

  1. International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 1-34012, Trieste, Italy

    Christian Kühne, Daniela Gardiol, Corrado Guarnaccia & Lawrence Banks

  2. Institute of Biophysics and X-Ray Structure Research, Austrian Academy of Sciences, Steyrergasse 17, A-8010, Graz, Austria

    Heinz Amenitsch

Authors
  1. Christian Kühne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Gardiol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Corrado Guarnaccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heinz Amenitsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lawrence Banks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kühne, C., Gardiol, D., Guarnaccia, C. et al. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6. Oncogene 19, 5884–5891 (2000). https://doi.org/10.1038/sj.onc.1203988

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203988

Keywords

This article is cited by

Search

Advanced search

Quick links